UPDATE: Goldman Sachs Lowers PT on Walgreen Company to $42

Goldman Sachs is out with its report today on Walgreen Company WAG, lowering its PT from $43 to $42. In its report, Goldman Sachs writes, "We cut our 12- month target price to $42 from $43 to reflect a more onerous downside case for WAG/ESRX ESRX, which drives 25% of our risk/reward analysis. Our target price is based on risk/reward and DCF." Goldman Sachs maintains Buy on WAG. At the time of posting, shares of WAG were trading at $35.06, up 0.49% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!